infra, as well as some other natural hexahydro-6H-
benzo[c]chromens.14 Large discrepancies in optical rota-
tion for the same compound have been reported, e.g.,
epiconicol.15 Several rationalizations have been suggested,
including racemization of the compounds during isolation, the
coexistence of enantiomers in nature, and the presence of an
enantiomeric excess in the opposite sense. Despite these
speculations, the solution to this discrepancy remains elusive.
Several elegant approaches have been implemented suc-
cessfully to achieve synthesis of the natural tetrahydro-6H-
benzo[c]chromenes, for example, the total synthesis of (+)-
machaeriol A, B,16 and nabilone.17 However, the key reaction
in these synthetic approaches used optically active starting
compounds or involved reactions with chiral substrates, e.g.,
citronellal or geranyl aldehyde. The key reactions were not
innately enantioselective, and the synthetic strategies lacked
diversity. Consequently, despite the success of the previous
synthetic strategies toward hexahydro-6H-benzo[c]chro-
menes, the development of an efficient and highly enanti-
oselective as well as diversity-oriented synthetic strategy
toward this skeleton remained an appealing challenge.
Recently, we developed a concise synthesis of the skeleton
of hexahydro-6H-benzo[c]chromenes via a quadruple cas-
cade18 organocatalytic19 multicomponent reaction, with
control over five stereocenters, in a one-pot operation
(Scheme 1).20,21 The diversity of the protocol was demon-
Figure 1
chromenes.
. Selected naturally occurring hexahydro-6H-benzo[c]-
cytotoxicity against P388 (murine leukemia), A549 (hu-
man lung carcinoma), HT29 (human colon carcinoma),
and CV1 (monkey kidney fibroblast) cells.12
Scheme 1
However, as shown in Figure 1, both absolute configura-
tions at the core of hexahydro-6H-benzo[c]chromenes have
been reported from nature sources,13 and the absolute
stereochemistries of some compounds are not clear. The
absolute configurations of these compounds shown in
the literature structures have been arbitrary. For instance,
both enantiomers of epiconicol have been presented in the
literature, and no attempts have been made to determine the
absolute configurations of conicol and epiconicol, vide
strated by the chemo-differentiating three-component reaction
(ABC type) with 3-methylbut-2-enal and ꢀ-aryl-R,ꢀ-unsatur-
(18) For selected recent examples of organocatalytic domino reactions,
see: (a) Zhang, F.-L.; Xu, A.-W.; Gong, Y.-F.; Wei, M.-H.; Yang, X.-L.
Chem.sEur. J. 2009, 15, 6815. (b) Carlone, A.; Cabrera, S.; Marigo, M.;
Jørgenson, K. A. Angew. Chem., Int. Ed. 2007, 46, 1101. (c) Enders, D.;
Hu¨ttl, M. R. M.; Runsink, J.; Raabe, G.; Wendt, B. Angew. Chem., Int. Ed.
2007, 46, 467. (d) Penon, O.; Carlone, A.; Mazzanti, A.; Locatelli, M.;
Sambri, L.; Bartoli, G.; Melchiorre, P. Chem.sEur. J. 2008, 14, 4788. (e)
Ishikawa, H.; Suzuki, T.; Hayashi, Y. Angew. Chem., Int. Ed. 2009, 48,
1304. (f) Marigo, M.; Schulte, T.; Franze´n, J.; Jørgensen, K. A. J. Am.
Chem. Soc. 2005, 127, 15710. (g) Zu, L.; Zhang, S.; Xie, H.; Wang, W.
Org. Lett. 2009, 11, 1627. (h) Franze´n, J.; Fisher, A. Angew. Chem., Int.
Ed. 2009, 48, 787.
(12) Carroll, A. R.; Bowden, B. F.; Coll, J. C. Aust. J. Chem. 1993, 46,
1079.
(13) For example, both enantiomers of sauchinone have been found in
nature, see: (a) Wang, E.-C.; Shih, M.-H.; Liu, M.-C.; Chen, M.-T.; Lee,
G.-H. Heterocycles 1996, 43, 969. (b) Seo, C.-S.; Lee, Y.-K.; Kim, Y.-J.;
Jung, J.-S.; Jahng, Y.; Chang, H.-W.; Song, D.-K.; Son, J.-K. Biol. Pharm.
Bull. 2008, 31, 523. (c) Sung, S. H.; Kim, Y. C. J. Nat. Prod. 2000, 63,
1019. (d) Hwang, B. Y.; Lee, J.-H.; Jung, H. S.; Kim, K.-S.; Nam, J. B.;
Hong, Y. S.; Paik, S.-G.; Lee, J. J. Planta Med. 2003, 69, 1096.
(14) (a) Refer to footnote 6 in ref 10. (b) Both the enantiomers of
epiconicol have been drawn in the literature. See refs 10, 11, and 12.
(15) (a) Optical rotation data for epiconicol: +58° (c 0.09) in ref 12
and +1.2° (c 0.6, CHCl3) in ref 10. (b) Refer to the footnote 13 in
ref 10.
(19) For recent reviews in organocatalysis, see: (a) Palomo, C.; Oiarbide,
M.; Lo´pez, R. Chem. Soc. ReV. 2009, 38, 632. (b) Zhang, Z.; Schreiner,
P. R. Chem. Soc. ReV. 2009, 38, 1187. (c) Lattanzi, A. Chem. Commun.
2009, 1452. (d) Xu, L. W.; Luo, J.; Lu, Y. Chem Commun. 2009, 1807. (e)
Enders, D.; Wang, C.; Liebich, J. X. Chem.sEur. J. 2009, 15, 11058. (f)
Bertelsen, S.; Jørgensen, K. A. Chem. Soc. ReV. 2009, 38, 2178. (g)
MacMillan, D. W. C. Nature 2008, 455, 304. (h) Carlos, F. B., III. Angew.
Chem., Int. Ed. 2008, 47, 42. (i) Dondoni, A.; Massi, A. Angew. Chem.,
Int. Ed. 2008, 47, 4638. (j) Melchiorre, P.; Marigo, M.; Carlone, A.; Bartoli,
G. Angew. Chem., Int. Ed. 2008, 47, 6138. (k) Mielgo, A.; Palomo, C.
Chem. Asian J. 2008, 3, 922. (l) Yu, X.; Wang, W. Org. Biomol. Chem.
2008, 6, 2037. (m) Kano, T.; Maruoka, K. Chem. Commun. 2008, 5465.
(n) Enders, D.; Narine, A. A. J. Org. Chem. 2008, 73, 7857. (o) Connon,
S. J. Chem. Commun. 2008, 2499.
(16) (a) Chittiboyina, A. G.; Reddy, C. R.; Watkins, E. B.; Avery, M. A.
Tetrahedron Lett. 2004, 45, 1689. (b) Huang, Q.; Wang, Q.; Zheng, J.;
Zhang, J.; Pan, X.; She, X. Tetrahedron 2007, 63, 1014. (c) Xia, L.; Lee,
Y. R. Synlett 2008, 1643. (d) Wang, Q.; Huang, Q.; Chen, B. O.; Lu, J.;
Wang, H.; She, X.; Pan, X. Angew. Chem., Int. Ed. 2006, 45, 3651. (e)
Lee, H. J.; Lee, Y. R.; Kim, S. H. HelV. Chim. Acta 2009, 92, 1404.
(17) (a) Huffman, J. W.; Joyner, H. H.; Lee, M. D.; Jordan, R. D.;
Pennington, W. T. J. Org. Chem. 1991, 56, 2081. (b) Archer, R. A.;
Blanchard, W. B.; Day, W. A.; Johnson, D. W.; Lavagnino, E. R.; Ryan,
C. W.; Baldwin, J. E. J. Org. Chem. 1977, 42, 2277.
Org. Lett., Vol. 12, No. 4, 2010
777